Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
Immunity, Inflammation and Disease · 2023-07 · 11 (7)
DOI: 10.1002/iid3.934 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 27.07.2023. Verfasst von Yaqi Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Jining Medical University, Jining, Shandong, China. Hauptthemen laut MEDLINE: Autoimmune Diseases, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The high prevalence of chronic inflammatory diseases or autoimmune reactions is a major source of concern and affects the quality of life of patients. Chronic inflammatory or autoimmune diseases are associated with many diseases in humans, including asthma, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease and cancer. Splenic tyrosine kinase (SYK) is a non–receptor tyrosine kinase that plays an important role in immune receptor signalling in immune and inflammatory responses.
Methods
This is a review article in which we searched for keywords “splenic tyrosine kinase”, “inflammation” and “autoimmune diseases” in published literature such as Pubmed and Web of Science to collect relevant information and then conducted a study focusing on the latest findings on the involvement of SYK in chronic inflammatory or autoimmune diseases.
Results
This paper reviews the regulation of Fcγ, NF–κB, B cell and T cell–related signalling pathways by SYK, which contributes to disease progression in chronic inflammatory and autoimmune diseases such as airway fibrosis, inflammatory skin disease and inflammatory bowel disease.
Conclusion
This paper shows that SYK plays an important role in chronic inflammatory and autoimmune diseases. syk targets hematological, autoimmune and other inflammatory diseases and therefore, inhibition of SYK expression or blocking its related pathways may provide new ideas for clinical prevention and treatment of inflammatory or autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, Jining Medical University, Jining, Shandong, China.
- Department of Gastroenterology, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.
ORCID-Profile: Fengqin Zhu, Guangxi Zhou
Zitieren
APA
Zhou, Y., Zhang, Y., Yu, W., Qin, Y., He, H., Dai, F., Wang, Y., Zhu, F., & Zhou, G. (2023). Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases. Immunity, Inflammation and Disease, 11(7). https://doi.org/10.1002/iid3.934
Vancouver
Zhou Y, Zhang Y, Yu W, Qin Y, He H, Dai F, et al. Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases. Immunity, Inflammation and Disease. 2023;11(7). doi:10.1002/iid3.934
BibTeX
@article{Zhou2023,
author = {Zhou, Yaqi and Zhang, Yaowen and Yu, Wei and Qin, Yufen and He, Heng and Dai, Fengxian and Wang, Yibo and Zhu, Fengqin and Zhou, Guangxi},
title = {Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases},
journal = {Immunity, Inflammation and Disease},
year = {2023},
volume = {11},
number = {7},
doi = {10.1002/iid3.934}
}
EUVIMED